Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

AKT signaling in normal and malignant cells

Abstract

AKT/protein kinase B (PKB) is a cardinal node in diverse signaling cascades important in both normal cellular physiology and various disease states. AKT signaling regulates cell proliferation and survival, cell growth (size), glucose metabolism, cell motility and angiogenesis. Aberrant regulation of these processes result in cellular perturbations considered hallmarks of cancer, and numerous studies testify to the frequent hyperactivation of AKT signaling in many human cancers. Various oncoproteins and tumor suppressors intersect the AKT signal transduction pathway and are activated or inactivated, respectively, in cancer. This issue of Oncogene Reviews includes a collection of perspectives on the normal cellular functions of various components of the AKT pathway, as well as biological consequences of alterations of these proteins as related to tumorigenesis. Two reviews focus on AKT regulation, one of which addresses various aspects of phosphoinositide metabolism, while the other emphasizes the role of AKT-interacting proteins in AKT activation. Several reviews highlight the role of major AKT substrates involved in cellular metabolism, transcription and translation; another focuses on the role of AKT signaling in epithelial–mesenchymal transition. Also included are articles on the involvement of AKT pathway deregulation in human cancer and certain hereditary cancer syndromes, as well as in murine models of cancer based on AKT pathway activation. Additional articles discuss current approaches to identify selective inhibitors of the AKT pathway.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Purchase on Springer Link

Instant access to full article PDF

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  • Ahmed NN, Franke TF, Bellacosa A, Datta K, Gonzalez-Portal ME, Taguchi T, Testa JR and Tsichlis PN . (1993). Oncogene, 8, 1957–1963.

  • Bellacosa A, Kumar CC, Di Cristofano A and Testa JR . (2005). Adv. Cancer Res., 93, 29–86.

  • Bellacosa A, Testa JR, Staal SP and Tsichlis PN . (1991). Science, 254, 274–277.

  • Cheng JQ, Lindsley CW, Cheng GZ, Yang H and Nicosia SV . Oncogene Rev., 24, 7482–7492.

  • Coffer PJ and Woodgett JR . (1991). Eur. J. Biochem., 201, 475–481.

  • Franke TF, Yang SI, Chan TO, Datta K, Kazlauskas A, Morrison DK, Kaplan DR and Tsichlis PN . (1995). Cell, 81, 727–736.

  • Hanahan D and Weinberg RA . (2000). Cell, 100, 57–70.

  • Jones PF, Jakubowicz T, Pitossi FJ, Maurer F and Hemmings BA . (1991). Proc. Natl. Acad. Sci. USA, 88, 4171–4175.

  • Staal SP . (1987). Proc. Natl. Acad. Sci USA, 84, 5034–5037.

  • Staal SP, Hartley JW and Rowe WP . (1977). Proc. Natl. Acad. Sci. USA, 74, 3065–3067.

Download references

Acknowledgements

This work was supported by NIH Grants CA77429, CA83638 (SPORE in Ovarian Cancer), CA57436 and CA06927, and by an appropriation from the Commonwealth of Pennsylvania to the Fox Chase Cancer Center.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Joseph R Testa.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Testa, J., Tsichlis, P. AKT signaling in normal and malignant cells. Oncogene 24, 7391–7393 (2005). https://doi.org/10.1038/sj.onc.1209100

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209100

Keywords

This article is cited by

Search

Quick links